Standard Biotools (LAB) Non-Current Assets (2010 - 2026)

Standard Biotools (LAB) has 17 years of Non-Current Assets data on file, last reported at $117.7 million in Q1 2026.

• On a quarterly basis, Non-Current Assets fell 50.05% year-over-year to $117.7 million in Q1 2026; TTM through Mar 2026 was $349.3 million, a 62.39% decrease from a year earlier, with the FY2025 full-year figure at $113.5 million, down 52.0% from the prior year.
• Non-Current Assets for Q1 2026 stood at $117.7 million, up from $113.5 million in the prior quarter.
• Over the last five years, Non-Current Assets for LAB reached as high as $236.5 million in Q4 2024 and fell as low as $50.9 million in Q2 2025.
• Historically, Non-Current Assets has averaged $173.4 million across 5 years, with a median of $181.5 million in 2022.
• Across the five-year window, Non-Current Assets surged 43.44% in 2024 and sank 77.73% in 2025, its largest moves.
• Year by year, Non-Current Assets stood at $181.5 million in 2022, then retreated by 9.17% to $164.9 million in 2023, then surged by 43.44% to $236.5 million in 2024, then plunged by 52.0% to $113.5 million in 2025, then grew by 3.68% to $117.7 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $117.7 million in Q1 2026, $113.5 million in Q4 2025, and $67.2 million in Q3 2025.